Gerard Criner

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Novartis
    Date added:
    03/12/2024
    Date updated:
    03/12/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Olympus
    Date added:
    03/12/2024
    Date updated:
    03/12/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    PulmonX
    Date added:
    03/12/2024
    Date updated:
    03/12/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Respironics Inc
    Date added:
    03/12/2024
    Date updated:
    03/12/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Respivant Sciences
    Date added:
    03/12/2024
    Date updated:
    03/12/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    The Implementation Group
    Date added:
    03/12/2024
    Date updated:
    03/12/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Verona Pharma
    Date added:
    03/12/2024
    Date updated:
    03/12/2024

Pages

Return to March 22, 2024 30th Advances in Pulmonary and Critical Care Medicine Conference